Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$259K Sell
623
-55
-8% -$27.6K 0.01% 587
2022
Q2
$323K Buy
678
+9
+1% +$5.02K 0.01% 532
2022
Q1
$447K Buy
669
+205
+44% +$137K 0.01% 482
2021
Q4
$369K Buy
464
+36
+8% +$28.6K 0.01% 521
2021
Q3
$319K Buy
428
+20
+5% +$15.7K 0.01% 537
2021
Q2
$282K Sell
408
-2
-0.5% -$1.32K 0.01% 540
2021
Q1
$253K Buy
+410
New +$227K 0.01% 497

Other funds holding ASML

RegentAtlantic Capital's ASML Position: Q3 2022 in Review

RegentAtlantic Capital reduced its ASML (ASML) stake by 8.1% in Q3 2022, selling an estimated $27.6K and leaving 623 shares worth $259K. The position accounts for 0.01% of the portfolio, ranked #587.

RegentAtlantic Capital first reported a position in ASML in Q1 2021 and has held it in 7 quarters since. The position peaked at $447K in Q1 2022. 884 funds tracked by Wall St. Rank hold ASML as of Q3 2022.

  • RegentAtlantic Capital held 623 shares of ASML worth $259K as of Q3 2022.
  • RegentAtlantic Capital sold 55 ASML shares in Q3 2022, an estimated $27.6K.
  • ASML made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #587 holding.
  • RegentAtlantic Capital first reported a position in ASML in Q1 2021 and has held it in 7 quarters since.
  • RegentAtlantic Capital's ASML position peaked at $447K in Q1 2022.
  • 884 funds tracked by Wall St. Rank held ASML as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.